-
Veteran Diagnosed with Mesothelioma after Decades-long Welding Career
An 81-year-old Navy veteran and his wife are seeking justice after he was recently diagnosed with mesothelioma. Richard Todd was diagnosed in June 2025 after decades of asbestos exposure starting with his naval aviation service aboard the USS Randolph from 1964 to1968, automotive repair, and nearly 30 years as a welder.
-
Italian Researchers Find Mesothelioma Tumors Can Transform Their Own Cells
Mesothelioma researchers from Milan, Italy, have discovered that mesothelioma cells can transform themselves into fibroblast-like cells within their tumors. Their findings challenge the conventional understanding of how the rare cancer’s microenvironment forms and functions.
-
Mesothelioma Advocates Cheered by $40 Million Johnson & Johnson Ovarian Cancer Verdict
Mesothelioma advocates are encouraged by the outcome of a closely watched lawsuit against Johnson & Johnson. A California jury awarded ovarian cancer victims Monica Kent and Deborah Schultz a combined $40 million verdict, agreeing that the company knew for years that its talc-based baby powder product was dangerous but failed to warn consumers about the
-
Lawsuit Blaming Johnson & Johnson Talc for Ovarian Cancer Goes to Los Angeles Jury
In a case that’s been closely watched by mesothelioma victims across the country, a Los Angeles jury is about to decide whether talc in Johnson & Johnson’s Baby Powder is responsible for two cases of ovarian cancer. Closing arguments presented yesterday signaled that the decision is about to be handed to the jury for deliberations.
-
Pembrolizumab-Lenvatinib Combination Delivers 60% Response Rate in Mesothelioma Patients
Mesothelioma patients whose disease progressed after receiving a first-line treatment of nivolumab plus ipilimumab achieved a 60 percent objective response rate when treated with second-line pembrolizumab plus lenvatinib therapy. Dutch researchers report that twenty patients experienced a median progression-free survival of 6.9 months and disease control rates of 90 percent at 3 months and 52.6
-
Do Popular Medications Present a Mesothelioma Risk?
Recent years have seen growing concerns about cosmetic talc’s role in causing mesothelioma. But talc’s use in consumer products extends far beyond body powders. Talc is found in four of the ten most commonly used medications in the United States, leading experts to question the FDA’s withdrawal of a proposed rule requiring cosmetic manufacturers to
-
Withdrawal of Proposed Talc Rule Sets Mesothelioma and Ovarian Cancer Prevention Back
Concerns about mesothelioma and ovarian cancer risks linked to cosmetics were revived this week as the FDA quietly withdrew its proposed regulation for standardizing testing for asbestos in talc-containing cosmetic products. The disappointing action took place on November 28, 2025, just under a year after the “Talc Rule” was proposed in keeping with a congressional
-
Widow Files Wrongful Death and Survival Claim Following Asbestosis Death
Mesothelioma is the deadliest asbestos-related disease, but it is just one of many serious illnesses caused by exposure to the toxic mineral. Asbestosis, a debilitating, progressive disease, can also lead to death, and that was the case for Timothy Murphy, who died of the disease after serving in the U.S. Navy and performing home repair
-
Court Addresses Asbestos Exposure Issues in Louisiana Mesothelioma Claim
After Erica Dandry Constanza and Monica Dandry Hallner’s father, Michael Dandry, Jr., died of malignant mesothelioma, the sisters filed a personal injury lawsuit accusing Avondale Shipyard and several other defendants of negligently exposing him to asbestos. In response, Avondale and defendant Paramount Global argue that his illness was caused by secondary and environmental exposure to
-
Asbestos Company’s Attempt to Evade Mesothelioma Liability Fails
In February 2025, Ernest Adams was diagnosed with malignant mesothelioma following decades of secondary and occupational exposure to asbestos. In filing a lawsuit against the companies he blames for his illness, he included Cummins, Inc. among those named as defendants, but provided no preliminary details about the company’s specific role in his illness. Though Cummins
-
Mesothelioma Risk Resurfaces as Asbestos is Discovered in Wind Turbine Brake Components
Mesothelioma has long been categorized as an occupational disease, as many industries historically put workers at risk of asbestos exposure. Despite efforts to eliminate the use of the toxic mineral, new concerns have been raised after chrysotile white asbestos was discovered in brake pads used in wind turbines at Goldwind Australia’s Cattle Hill Wind Farm
-
Mesothelioma Cases Highlight Contrasting Treatment Responses and Diagnostic Challenges
Mesothelioma is a notoriously difficult disease to treat, and the fact that it appears in different areas of the body makes diagnosis and clinical approaches even more challenging. A recent study published by researchers at Harbin Medical University in Harbin, China, provides case reports demonstrating dramatically different treatment outcomes in two patients with this rare
-
Mesothelioma Risk Remains After FDA Withdraws Asbestos Testing Rule for Talc Products
Increasing evidence of asbestos in talc has led to thousands of lawsuits filed by mesothelioma and ovarian cancer victims who blame contaminated cosmetics for their illnesses. The Cosmetics Modernization Act of 2022 aimed to eliminate consumer risk by requiring asbestos testing of cosmetics, medications, and food; however, today the Food and Drug Administration announced that
-
Mesothelioma Incidence Rose from 1999 to 2011, Then Declined Through 2020
A group of international researchers has published a noteworthy article concluding that the number of U.S. mesothelioma cases significantly increased from 1999 through 2011, then gradually declined through 2020. The scientists noted the higher incidence of the asbestos-related disease among individuals aged 75 years and older, men, and White populations. The group concludes that enhanced
-
Mesothelioma and Ovarian Cancer Claims Against Johnson & Johnson Go to California Jury
Mesothelioma victims are closely watching a California state court, as opening statements began in a bellweather ovarian cancer claim against Johnson & Johnson. The trial involves consolidated claims from two plaintiffs: Monica Kent, who is currently suffering from ovarian cancer, and the husband of Deborah Schultz, who died from the disease. The trial marks the
-
Mesothelioma Patient and Family Input Guides UK End-of-Life Study
Mesothelioma patients and their families in the United Kingdom are being asked to participate in groundbreaking research exploring how caregivers can better support decision-making about where to receive end-of-life care and die—whether at home, in hospital, in hospice, or in a care or nursing home. Recognizing that the place of death has a profound impact
-
Mesothelioma Victims Face Uncertainty as Asbestos Liability Insurance Reserves Drop
Mesothelioma victims and their families have few paths to getting justice from the companies whose negligence led to their illnesses. Filing personal injury lawsuits for compensation remains one of the best options, but a recent report is driving new concerns about future success. According to an S&P Global Market Intelligence analysis released Monday, insurance companies’
-
Investigational Mesothelioma Treatment Achieves 32% Response Rate in Treatment-Resistant Patients
An unfortunately high percentage of mesothelioma patients are diagnosed with treatment-resistant disease, leaving them with even fewer options in the face of an already bleak prognosis. But attendees at October’s European Society for Medical Oncology Congress in Berlin learned that biotech company Vivace Therapeutics achieved a 32 percent objective response rate with its investigational drug
-
Mesothelioma Diagnosis Improved by AI-Generated Atlas
Doctors working to confirm mesothelioma diagnoses are often challenged by the rarity of the disease and the diverse ways that it can manifest. But a study published in the journal Nature Communications details work done by a group of Scottish researchers, which offers a powerful new diagnostic tool created using artificial intelligence.
-
Saying Goodyear Waived its Removal Rights, Judge Sides with Mesothelioma Victim
Sergio Morris blames his mesothelioma diagnosis on three different sources of asbestos exposure and filed lawsuits against multiple companies. As one of the named defendants, Goodyear Tire & Rubber removed the case to federal court, but that decision was reversed. When Goodyear made a second attempt, the federal judge hearing the case said that the
